These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24817964)

  • 21. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma.
    Krishna A; Bhatt MLB; Singh V; Singh S; Gangwar PK; Singh US; Kumar V; Mehrotra D
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):867-874. PubMed ID: 29582647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
    Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
    PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways.
    Wu XM; Chen WQ; Hu YW; Cao L; Nie P; Chang MX
    Front Immunol; 2018; 9():726. PubMed ID: 29692779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
    Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
    PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of T Lymphoma Invasion and Metastasis 1 (TIAM1) expression in oral squamous cell carcinoma.
    Lin L; You J; Qian Y; Han Y; Xiong H; Zhu T; Xia K; Su T
    J Biochem Mol Toxicol; 2017 Apr; 31(4):. PubMed ID: 27862620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Deletion of NOD1 Prevents Cardiac Ca
    Gil-Fernández M; Navarro-García JA; Val-Blasco A; González-Lafuente L; Martínez JC; Rueda A; Tamayo M; Morgado JL; Zaragoza C; Ruilope LM; Delgado C; Ruiz-Hurtado G; Fernández-Velasco M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cigarette smoking induces the activation of RIP2/caspase-12/NF-
    Qian Y; Wang W; Chen D; Zhu Y; Wang Y; Wang X
    PeerJ; 2022; 10():e14330. PubMed ID: 36353608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
    Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
    Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
    Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development.
    Ikehata N; Takanashi M; Satomi T; Watanabe M; Hasegawa O; Kono M; Enomoto A; Chikazu D; Kuroda M
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2227-2234. PubMed ID: 29269299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
    Yan R; Liu Z
    Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
    Liu Z; Li H; Fan S; Lin H; Lian W
    Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.